Skip to main content

Table 2 Study population characteristics at follow-up

From: Sex difference in clot lysability and association to coronary artery calcification

Follow-up, N = 163 Men (n = 79) Women (n = 84) p value
Born
 1949 (n = 70) 30 (43) 40 (57)  
 1959 (n = 93) 49 (53) 44 (47) 0.21
Tobacco use
 Never (n = 76) 34 (45) 42 (55)  
 Prior/current (n = 87) 45 (52) 42 (48) 0.47
Systolic blood pressure, mmHg
Diastolic blood pressure, mmHg
140 (17)
81 (8)
133 (16)
72 (9)
0.013
< 0.001
Body mass index, kg/m2 28.1 (4.2) 26.9 (4.7) 0.063
Agatston score, U 9 (0–115) 0 (0–26) 0.002
ΔAgatston score, U 4 (0–49) 0 (0–10) 0.012
Total cholesterol, mmol/l
LDL cholesterol, mmol/l
HDL cholesterol, mmol/l
Triglycerides, mmol/l
5.31 (0.85)
3.33 (0.80)
1.30 (1.10–1.40)
1.82 (0.97)
5.54 (0.92)
3.30 (0.93)
1.55 (1.40–1.75)
1.50 (0.89)
0.10
0.80
< 0.001
0.032
C-reactive protein, mg/l 0.74 (0.46–1.61) 0.70 (0.30–2.18) 0.74
Fibrinogen, μmol/l 8.9 (7.7–10.3) 9.5 (8.4–11.1) 0.056
PAI-1, ng/ml 21.7 (15.4–27.5) 20.1 (15.0–30.3) 0.69
Fibrin clot lysability, % 52.1 (20.5) 47.2 (22.3) 0.14
  1. Values are presented as mean (SD), median (IQR), or number (%). Information on Agatston score is missing on one participant
  2. LDL low-density lipoprotein, HDL high-density lipoprotein, PAI-1 plasminogen activator inhibitor type 1